Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

[Kinesiophobia in patients with cardiovascular disease].

Gołba A, Soral T, Młynarska A, Dzierzawa M, Kowalik-Kabat A, Dębska B, Kulesza P, Sanecki K, Pol-Romik J, Żurawski P, Pieczara M, Durmała J, Marcisz C, Gołba KS.

Wiad Lek. 2018;71(9):1653-1660. Polish.

PMID:
30737918
2.

15-Copper(ii)-containing 36-tungsto-4-silicates(iv) [Cu15O2(OH)10X(A-α-SiW9O34)4]25- (X = Cl, Br): synthesis, structure, magnetic properties, and electrocatalytic CO2 reduction.

Bassil BS, Haider A, Ibrahim M, Mougharbel AS, Bhattacharya S, Christian JH, Bindra JK, Dalal NS, Wang M, Zhang G, Keita B, Rutkowska IA, Kulesza PJ, Kortz U.

Dalton Trans. 2018 Sep 11;47(35):12439-12448. doi: 10.1039/c8dt01896k.

PMID:
30132769
3.

Amperometric detector for gas chromatography based on a silica sol-gel solid electrolyte.

Steinecker WH, Miecznikowski K, Kulesza PJ, Sandlin ZD, Cox JA.

Talanta. 2017 Nov 1;174:1-6. doi: 10.1016/j.talanta.2017.05.074. Epub 2017 May 27.

PMID:
28738554
4.

Solar-Driven Water Oxidation and Decoupled Hydrogen Production Mediated by an Electron-Coupled-Proton Buffer.

Bloor LG, Solarska R, Bienkowski K, Kulesza PJ, Augustynski J, Symes MD, Cronin L.

J Am Chem Soc. 2016 Jun 1;138(21):6707-10. doi: 10.1021/jacs.6b03187. Epub 2016 May 18.

5.

Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors.

Bondarenko G, Ugolkov A, Rohan S, Kulesza P, Dubrovskyi O, Gursel D, Mathews J, O'Halloran TV, Wei JJ, Mazar AP.

Neoplasia. 2015 Sep;17(9):735-741. doi: 10.1016/j.neo.2015.09.004.

6.

Nanocomposite semi-solid redox ionic liquid electrolytes with enhanced charge-transport capabilities for dye-sensitized solar cells.

Rutkowska IA, Marszalek M, Orlowska J, Ozimek W, Zakeeruddin SM, Kulesza PJ, Grätzel M.

ChemSusChem. 2015 Aug 10;8(15):2560-8. doi: 10.1002/cssc.201403475. Epub 2015 Jun 26.

PMID:
26119519
7.

CO₂ electroreduction at bare and Cu-decorated Pd pseudomorphic layers: catalyst tuning by controlled and indirect supporting onto Au(111).

Januszewska A, Jurczakowski R, Kulesza PJ.

Langmuir. 2014 Dec 2;30(47):14314-21. doi: 10.1021/la5025247. Epub 2014 Nov 19.

PMID:
25350872
8.

Enhanced water splitting at thin film tungsten trioxide photoanodes bearing plasmonic gold-polyoxometalate particles.

Solarska R, Bienkowski K, Zoladek S, Majcher A, Stefaniuk T, Kulesza PJ, Augustynski J.

Angew Chem Int Ed Engl. 2014 Dec 15;53(51):14196-200. doi: 10.1002/anie.201408374. Epub 2014 Oct 21.

PMID:
25332175
9.

A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast.

Lee O, Page K, Ivancic D, Helenowski I, Parini V, Sullivan ME, Margenthaler JA, Chatterton RT Jr, Jovanovic B, Dunn BK, Heckman-Stoddard BM, Foster K, Muzzio M, Shklovskaya J, Skripkauskas S, Kulesza P, Green D, Hansen NM, Bethke KP, Jeruss JS, Bergan R, Khan SA.

Clin Cancer Res. 2014 Jul 15;20(14):3672-82. doi: 10.1158/1078-0432.CCR-13-3045.

11.

Improving diversity in cancer research trials: the story of the Cancer Disparities Research Network.

Simon MA, de la Riva EE, Bergan R, Norbeck C, McKoy JM, Kulesza P, Dong X, Schink J, Fleisher L.

J Cancer Educ. 2014 Jun;29(2):366-74. doi: 10.1007/s13187-014-0617-y.

12.
13.

Novel Phenotypic Fluorescent Three-Dimensional Co-Culture Platforms for Recapitulating Tumor in vivo Progression and for Personalized Therapy.

Fang C, Man YG, Cuttitta F, Stetler-Stevenson W, Salomon D, Mazar A, Kulesza P, Rosen S, Avital I, Stojadinovic A, Jewett A, Jiang B, Mulshine J.

J Cancer. 2013 Dec 1;4(9):755-63. doi: 10.7150/jca.7813. eCollection 2013.

14.

Beyond the standard of care: the role of cytopathology in molecular testing of cancer.

Kulesza P.

Cancer Treat Res. 2014;160:273-82. doi: 10.1007/978-3-642-38850-7_11. Review. No abstract available.

PMID:
24092374
15.

The efficacy of on-site evaluation for identification of transplant pancreas.

Berg N, Gehl J, Vande Haar M, Balco M, Kulesza P.

Acta Cytol. 2013;57(5):443-6. doi: 10.1159/000348309. Epub 2013 Sep 7.

16.
17.

A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia.

Wong SJ, Campbell B, Massey B, Lynch DP, Cohen EEW, Blair E, Selle R, Shklovskaya J, Jovanovic BD, Skripkauskas S, Dew A, Kulesza P, Parimi V, Bergan RC, Szabo E.

Oral Oncol. 2013 Sep;49(9):970-976. doi: 10.1016/j.oraloncology.2013.05.011. Epub 2013 Jul 8.

18.

Central pathology review for phase III clinical trials: the enabling effect of virtual microscopy.

Mroz P, Parwani AV, Kulesza P.

Arch Pathol Lab Med. 2013 Apr;137(4):492-5. doi: 10.5858/arpa.2012-0093-RA.

PMID:
23544938
19.

Toward more efficient bioelectrocatalytic oxidation of ethanol for amperometric sensing and biofuel cell technology.

Kowalewska B, Kulesza PJ.

Anal Chem. 2012 Nov 6;84(21):9564-71. doi: 10.1021/ac3021328. Epub 2012 Oct 25.

PMID:
23066916
20.

Identification and characterization of nucleolin as a COUP-TFII coactivator of retinoic acid receptor β transcription in breast cancer cells.

Litchfield LM, Riggs KA, Hockenberry AM, Oliver LD, Barnhart KG, Cai J, Pierce WM Jr, Ivanova MM, Bates PJ, Appana SN, Datta S, Kulesza P, McBryan J, Young LS, Klinge CM.

PLoS One. 2012;7(5):e38278. doi: 10.1371/journal.pone.0038278. Epub 2012 May 31.

21.

Estradiol modulates post-ischemic cerebral vascular remodeling and improves long-term functional outcome in a rat model of stroke.

Ardelt AA, Carpenter RS, Lobo MR, Zeng H, Solanki RB, Zhang A, Kulesza P, Pike MM.

Brain Res. 2012 Jun 21;1461:76-86. doi: 10.1016/j.brainres.2012.04.024. Epub 2012 Apr 21.

22.

Optimal specimen processing of fine needle aspirates of non-Hodgkin lymphoma.

Shetuni B, Lakey M, Kulesza P.

Diagn Cytopathol. 2012 Nov;40(11):984-6. doi: 10.1002/dc.21780. Epub 2011 Oct 11.

PMID:
21987470
23.

Targeting ErbB3-mediated stromal-epithelial interactions in pancreatic ductal adenocarcinoma.

Liles JS, Arnoletti JP, Kossenkov AV, Mikhaylina A, Frost AR, Kulesza P, Heslin MJ, Frolov A.

Br J Cancer. 2011 Aug 9;105(4):523-33. doi: 10.1038/bjc.2011.263. Epub 2011 Jul 26.

24.

Emerging concepts in the pathology and molecular biology of advanced non-small cell lung cancer.

Kulesza P, Ramchandran K, Patel JD.

Am J Clin Pathol. 2011 Aug;136(2):228-38. doi: 10.1309/AJCPO66OIRULFNLZ. Review.

PMID:
21757595
25.

The utility of fine needle aspiration for diagnosis of extrapulmonary coccidioidomycosis: a case report and discussion.

Berg N, Ryscavage P, Kulesza P.

Clin Med Res. 2011 Nov;9(3-4):130-3. doi: 10.3121/cmr.2011.993. Epub 2011 May 11.

26.

Metastatic chromophobe renal cell carcinoma in pleural fluid cytology: review of literature and report of a case.

Davion S, Rohan S, Nayar R, Kulesza P.

Diagn Cytopathol. 2012 Sep;40(9):826-9. doi: 10.1002/dc.21671. Epub 2011 Apr 6. Review.

PMID:
21472872
27.

Fine-needle aspiration of renal cell carcinoma: is accurate Fuhrman grading possible on cytologic material?

Bishop JA, Hosler GA, Kulesza P, Erozan YS, Ali SZ.

Diagn Cytopathol. 2011 Mar;39(3):168-71. doi: 10.1002/dc.21352.

PMID:
21319316
28.

Enhanced oxygen reduction at Pd catalytic nanoparticles dispersed onto heteropolytungstate-assembled poly(diallyldimethylammonium)-functionalized carbon nanotubes.

Wang D, Lu S, Kulesza PJ, Li CM, De Marco R, Jiang SP.

Phys Chem Chem Phys. 2011 Mar 14;13(10):4400-10. doi: 10.1039/c0cp02036b. Epub 2011 Jan 19.

PMID:
21249246
29.

Phase I trial of oxaliplatin, infusional 5-fluorouracil, and leucovorin (FOLFOX4) with erlotinib and bevacizumab in colorectal cancer.

Messersmith WA, Jimeno A, Jacene H, Zhao M, Kulesza P, Laheru DA, Kahn Y, Spira A, Dancey J, Iacobuzio-Donahue C, Donehower RC, Carducci M, Rudek MA, Hidalgo M.

Clin Colorectal Cancer. 2010 Dec;9(5):297-304. doi: 10.3816/CCC.2010.n.043.

30.

ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma.

Liles JS, Arnoletti JP, Tzeng CW, Howard JH, Kossenkov AV, Kulesza P, Heslin MJ, Frolov A.

Cancer Biol Ther. 2010 Sep 15;10(6):555-63. Epub 2010 Sep 30.

31.

The cytologic criteria of malignancy.

Fischer AH, Zhao C, Li QK, Gustafson KS, Eltoum IE, Tambouret R, Benstein B, Savaloja LC, Kulesza P.

J Cell Biochem. 2010 Jul 1;110(4):795-811. doi: 10.1002/jcb.22585.

PMID:
20564180
32.

Epidermal growth factor receptor (EGFR) intron 1 polymorphism and clinical outcome in pancreatic adenocarcinoma.

Frolov A, Liles JS, Kossenkov AV, Tzeng CW, Jhala N, Kulesza P, Varadarajulu S, Eloubeidi M, Heslin MJ, Arnoletti JP.

Am J Surg. 2010 Sep;200(3):398-405. doi: 10.1016/j.amjsurg.2009.10.014. Epub 2010 Apr 21.

33.

Localization of angiopoietin-1 and Tie2 immunoreactivity in rodent ependyma and adjacent blood vessels suggests functional relationships.

Horton BN, Solanki RB, Rajneesh KF, Kulesza P, Ardelt AA.

J Histochem Cytochem. 2010 Jan;58(1):53-60. doi: 10.1369/jhc.2009.954610. Epub 2009 Sep 28.

34.

Adsorption of 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonate) on multiwalled carbon nanotubes-silicate film: application to bioelectrocatalytic dioxygen reduction.

Jönsson M, Szot K, Niedziolka J, Rogalski J, Karnicka K, Kulesza P, Opallo M.

J Nanosci Nanotechnol. 2009 Apr;9(4):2346-52.

PMID:
19437974
35.

Retroperitoneal and intra-abdominal sarcoma.

Liles JS, Tzeng CW, Short JJ, Kulesza P, Heslin MJ.

Curr Probl Surg. 2009 Jun;46(6):445-503. doi: 10.1067/j.cpsurg.2009.01.004. Review. No abstract available.

PMID:
19414097
36.

Phosphomolybdate-modified multi-walled carbon nanotubes as effective mediating systems for electrocatalytic reduction of bromate.

Skunik M, Kulesza PJ.

Anal Chim Acta. 2009 Jan 12;631(2):153-60. doi: 10.1016/j.aca.2008.10.031. Epub 2008 Nov 1.

PMID:
19084620
37.

Intrapancreatic schwannoma diagnosed by endoscopic ultrasound-guided fine-needle aspiration cytology.

Li S, Ai SZ, Owens C, Kulesza P.

Diagn Cytopathol. 2009 Feb;37(2):132-5. doi: 10.1002/dc.20985.

PMID:
19031416
38.

Evaluation of the novel mitotic modulator ON 01910.Na in pancreatic cancer and preclinical development of an ex vivo predictive assay.

Jimeno A, Chan A, Cusatis G, Zhang X, Wheelhouse J, Solomon A, Chan F, Zhao M, Cosenza SC, Ramana Reddy MV, Rudek MA, Kulesza P, Donehower RC, Reddy EP, Hidalgo M.

Oncogene. 2009 Jan 29;28(4):610-8. doi: 10.1038/onc.2008.424. Epub 2008 Nov 24.

39.

Pharmacodynamic-guided modified continuous reassessment method-based, dose-finding study of rapamycin in adult patients with solid tumors.

Jimeno A, Rudek MA, Kulesza P, Ma WW, Wheelhouse J, Howard A, Khan Y, Zhao M, Jacene H, Messersmith WA, Laheru D, Donehower RC, Garrett-Mayer E, Baker SD, Hidalgo M.

J Clin Oncol. 2008 Sep 1;26(25):4172-9. doi: 10.1200/JCO.2008.16.2347.

40.

ABTS-modified multiwalled carbon nanotubes as an effective mediating system for bioelectrocatalytic reduction of oxygen.

Karnicka K, Miecznikowski K, Kowalewska B, Skunik M, Opallo M, Rogalski J, Schuhmann W, Kulesza PJ.

Anal Chem. 2008 Oct 1;80(19):7643-8. doi: 10.1021/ac8011297. Epub 2008 Aug 27.

PMID:
18729478
41.

Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer.

Jimeno A, Tan AC, Coffa J, Rajeshkumar NV, Kulesza P, Rubio-Viqueira B, Wheelhouse J, Diosdado B, Messersmith WA, Iacobuzio-Donahue C, Maitra A, Varella-Garcia M, Hirsch FR, Meijer GA, Hidalgo M.

Cancer Res. 2008 Apr 15;68(8):2841-9. doi: 10.1158/0008-5472.CAN-07-5200.

42.

Endoscopic ultrasound-guided fine-needle aspiration: sampling, pitfalls, and quality management.

Kulesza P, Eltoum IA.

Clin Gastroenterol Hepatol. 2007 Nov;5(11):1248-54. Review.

PMID:
17981244
43.

Spring cabbage peroxidases--potential tool in biocatalysis and bioelectrocatalysis.

Belcarz A, Ginalska G, Kowalewska B, Kulesza P.

Phytochemistry. 2008 Feb;69(3):627-36. Epub 2007 Sep 29.

PMID:
17904598
44.

Analysis of charge transport in gels containing polyoxometallates using methods of different sensitivity to migration.

Caban K, Lewera A, Zukowska GZ, Kulesza PJ, Stojek Z, Jeffrey KR.

Anal Chim Acta. 2006 Aug 4;575(1):144-50. Epub 2006 May 27.

PMID:
17723584
45.

Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy.

Fayad LM, Barker PB, Jacobs MA, Eng J, Weber KL, Kulesza P, Bluemke DA.

AJR Am J Roentgenol. 2007 Jun;188(6):1513-20.

PMID:
17515370
46.

Estradiol augments peri-infarct cerebral vascular density in experimental stroke.

Ardelt AA, Anjum N, Rajneesh KF, Kulesza P, Koehler RC.

Exp Neurol. 2007 Jul;206(1):95-100. Epub 2007 Apr 18.

48.

Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy.

Jimeno A, Kulesza P, Wheelhouse J, Chan A, Zhang X, Kincaid E, Chen R, Clark DP, Forastiere A, Hidalgo M.

Br J Cancer. 2007 Mar 26;96(6):952-9. Epub 2007 Mar 6.

49.

Hybrid bioelectrocatalyst for hydrogen peroxide reduction: immobilization of enzyme within organic-inorganic film of structured Prussian Blue and PEDOT.

Ernst A, Makowski O, Kowalewska B, Miecznikowski K, Kulesza PJ.

Bioelectrochemistry. 2007 Sep;71(1):23-8. Epub 2007 Jan 10.

PMID:
17289445
50.

Assessment of celecoxib pharmacodynamics in pancreatic cancer.

Jimeno A, Amador ML, Kulesza P, Wang X, Rubio-Viqueira B, Zhang X, Chan A, Wheelhouse J, Kuramochi H, Tanaka K, Danenberg K, Messersmith WA, Almuete V, Hruban RH, Maitra A, Yeo CJ, Hidalgo M.

Mol Cancer Ther. 2006 Dec;5(12):3240-7.

Supplemental Content

Loading ...
Support Center